🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase IB/II trial that will investigate the safety, tolerability ...
Status
Recruiting
Location
Houston Methodist Neal Cancer Center
Start Date
2024-07-29
Trial ID
NCT06536413
Multiple myeloma (MM) patients who develop bortezomib and lenalidomide-resi...
Status
Completed
Location
VU University Medical Center
Start Date
2016-07-06
Trial ID
NCT02751255
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2001-02
Trial ID
NCT00004188
Treatments Being Tested
Utilizing the Crosstalk Among Chicoric Acid, 13-Cis Retinoic Acid(Aerosoliz...
Status
Unknown
Location
Kafr El-sheikh University
Start Date
2021-12
Trial ID
NCT05077813
Treatments Being Tested
The purpose of this study is to find out what effects, good and/or bad, the...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2010-08-12
Trial ID
NCT01183429
Treatments Being Tested
The purpose of this study is to evaluate safety of the triple COG schema wi...
Status
Completed
Location
Hospital Sant Joan de Deu
Start Date
2014-11-26
Trial ID
NCT02169609
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of combined ...
Status
Completed
Location
University of Colorado Hospital
Start Date
2015-12-17
Trial ID
NCT02403778
Treatments Being Tested
This is a Phase I study designed to determine the MTD and assess the toxici...
Status
Terminated
Location
Phoenix Children's Hospital
Start Date
2007-09-01
Trial ID
NCT00852709
Treatments Being Tested
Investigating the potential role of Aerosolized retinoic acid, a potent Vit...
Status
Unknown
Location
Quan Liu
Start Date
2021-11
Trial ID
NCT05002530